COMPLETE REGRESSION OF MOUSE HEPATOMA TRANSPLANTED AFTER PARTIAL-HEPATECTOMY AND THE IMMUNOLOGICAL MECHANISM OF SUCH REGRESSION
- 1 October 1986
- journal article
- research article
- Vol. 46 (10) , 5049-5053
Abstract
We have investigated the effect of partial hepatectomy (HEP) on tumor growth. MH-134 hepatoma cells, which were inoculated in syngeneic C3H/He mice from 3 to 10 days after HEP, grew with a linear increase in size unit 7 days, began to regress, and disappeared 14 days after the inoculation. The survival rate was 100%, and the recurrence of tumor was not observed during the following 4 mo. On the other hand, the growth of another syngeneic tumor, X-5563, and of an allogeneic Ehrlich tumor was not affected by HEP. When MH-134 tumor cells were inoculated 7 days before or 15 days after HEP, tumor regression was not observed. The Winn assay showed the presence of tumor-neutralizing activity in spleen cells of MH-134 tumor-regressed mice. Cytotoxic activity against MH-13 tumor cells was also detected in the spleen cells. Analysis by using monoclonal antibodies showed that the effector cells were Thy-1+ and Lyt-2+ cells. Thus, HEP and the following liver cell regeneration may play a role in augmentation of specific immune response to the transplanted hepatoma cells.This publication has 11 references indexed in Scilit:
- Transient expression of interleukin 2 receptors. Consequences for T cell growth.The Journal of Experimental Medicine, 1983
- Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics.The Journal of Immunology, 1983
- Regeneration and the immune system I. In vitro and in vivo activation of lymphocytes by liver regeneration and the role of Kupffer cells in stimulationEuropean Journal of Immunology, 1983
- Regeneration and the immune system II. Suppressor activities of lymphocytes activated in vivo by liver regeneration and their genetic controlEuropean Journal of Immunology, 1983
- STUDIES ON COMBINATION ANTI-TUMOR THERAPY - COMBINATION THERAPY OF MURINE TUMORS WITH LENTINAN PLUS LIPOPOLYSACCHARIDE PLUS CYCLOPHOSPHAMIDE1982
- Liver and immune responses V: Regenerating liver cells activate syngeneic lymphocytesCell Differentiation, 1979
- PREFERENTIAL GENERATION OF KILLER OR HELPER T-LYMPHOCYTE ACTIVITY DIRECTED TO TUMOR-ASSOCIATED TRANSPLANTATION ANTIGENS1976
- PROLIFERATIVE ACTIVITY OF THE LYMPHATIC TISSUES OF RATS AS STUDIED WITH TRITIUM-LABELED THYMIDINEThe Journal of Experimental Medicine, 1964
- IMMUNE MECHANISMS IN HOMOTRANSPLANTATION .2. QUANTITATIVE ASSAY OF IMMUNOLOGIC ACTIVITY OF LYMPHOID CELLS STIMULATED BY TUMOR HOMOGRAFTS1961
- Experiments on an Ascites Hepatoma. III. The Conversion of Mouse Hepatomas into the Ascites FormJNCI Journal of the National Cancer Institute, 1956